Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1393801.RAD3aWP2nP60bGqYCbG40i11k5Lah1e0RQY-NbqnHy0G4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1393801.RAD3aWP2nP60bGqYCbG40i11k5Lah1e0RQY-NbqnHy0G4130_assertion type Assertion NP1393801.RAD3aWP2nP60bGqYCbG40i11k5Lah1e0RQY-NbqnHy0G4130_head.
- NP1393801.RAD3aWP2nP60bGqYCbG40i11k5Lah1e0RQY-NbqnHy0G4130_assertion description "[The plasma levels of HIV-1 RNA, tumor necrosis factor alpha (TNF-alpha), soluble receptors type II of TNF-alpha (sTNF-alpha RII), soluble receptors of interleukin-4 (sR IL-4), interleukin-6 (IL-6), soluble receptors of interleukin-6 (sR IL-6), granulocyte macrophage colony stimulating factor (GM-CSF), soluble receptors of GM-CSF (sR GM-CSF), RANTES, MIP-1 alpha and MIP-1 beta were measured in 80 HIV-infected patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1393801.RAD3aWP2nP60bGqYCbG40i11k5Lah1e0RQY-NbqnHy0G4130_provenance.
- NP1393801.RAD3aWP2nP60bGqYCbG40i11k5Lah1e0RQY-NbqnHy0G4130_assertion evidence source_evidence_literature NP1393801.RAD3aWP2nP60bGqYCbG40i11k5Lah1e0RQY-NbqnHy0G4130_provenance.
- NP1393801.RAD3aWP2nP60bGqYCbG40i11k5Lah1e0RQY-NbqnHy0G4130_assertion SIO_000772 9561379 NP1393801.RAD3aWP2nP60bGqYCbG40i11k5Lah1e0RQY-NbqnHy0G4130_provenance.
- NP1393801.RAD3aWP2nP60bGqYCbG40i11k5Lah1e0RQY-NbqnHy0G4130_assertion wasDerivedFrom befree-2016 NP1393801.RAD3aWP2nP60bGqYCbG40i11k5Lah1e0RQY-NbqnHy0G4130_provenance.
- NP1393801.RAD3aWP2nP60bGqYCbG40i11k5Lah1e0RQY-NbqnHy0G4130_assertion wasGeneratedBy ECO_0000203 NP1393801.RAD3aWP2nP60bGqYCbG40i11k5Lah1e0RQY-NbqnHy0G4130_provenance.